Search Results - "RAYMAN, Patricia"
-
1
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial
Published in The lancet oncology (01-09-2016)“…Summary Background A subset of patients with metastatic renal-cell carcinoma show indolent growth of metastases. Because of the toxicity and non-curative…”
Get full text
Journal Article -
2
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Published in Clinical cancer research (15-03-2009)“…Purpose: Immune dysfunction reported in renal cell carcinoma (RCC) patients may contribute to tumor progression. Myeloid-derived suppressor cells (MDSC)…”
Get full text
Journal Article -
3
Cancer Stem Cell‐Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Published in Stem cells (Dayton, Ohio) (01-08-2016)“…Shifting the balance away from tumor‐mediated immune suppression toward tumor immune rejection is the conceptual foundation for a variety of immunotherapy…”
Get full text
Journal Article -
4
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
Published in Clinical cancer research (15-10-2008)“…Purpose: Immune dysfunction is well documented in renal cell carcinoma (RCC) patients and likely contributes to tumor evasion. This dysfunction includes a…”
Get full text
Journal Article -
5
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2011)“…To assess the accumulation of myeloid-derived suppressor cells (MDSCs) in the peripheral blood of patients with glioma and to define their heterogeneity and…”
Get full text
Journal Article -
6
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Published in Cancer research (Chicago, Ill.) (01-05-2010)“…The antiangiogenic drug sunitinib is a receptor tyrosine kinase inhibitor with significant, yet not curative, therapeutic effects in metastatic renal cell…”
Get full text
Journal Article -
7
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
Published in Clinical cancer research (05-01-2024)“…A single arm, phase II trial of carboplatin, nab-paclitaxel, and pembrolizumab (CNP) in metastatic triple-negative breast cancer (mTNBC) was designed to…”
Get full text
Journal Article -
8
Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection
Published in PLoS pathogens (01-11-2020)“…The interferon-induced tetratricopeptide repeat protein (Ifit2) protects mice from lethal neurotropic viruses. Neurotropic coronavirus MHV-RSA59 infection of…”
Get full text
Journal Article -
9
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
Published in Oncoimmunology (31-12-2023)“…The tumor microenvironment (TME) in ovarian cancer (OC) is characterized by immune suppression, due to an abundance of suppressive immune cells populations. To…”
Get full text
Journal Article -
10
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
Published in Journal for immunotherapy of cancer (16-05-2018)“…Talimogene Laherparepvec (T-VEC) is an oncolytic virus approved as an intratumoral therapy for treating unresectable stage IIIB-IV metastatic melanoma. The…”
Get full text
Journal Article -
11
Unfolded Protein Response Differentially Regulates TLR4-Induced Cytokine Expression in Distinct Macrophage Populations
Published in Frontiers in immunology (21-06-2019)“…Cellular stress responses are often engaged at sites of inflammation and can alter macrophage cytokine production. We now report that macrophages in distinct…”
Get full text
Journal Article -
12
Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer
Published in Oncotarget (22-09-2017)“…Increased circulating levels of apolipoprotein A-I (apoA-I), the major protein of high-density lipoprotein (HDL), by genetic manipulation or infusion, protects…”
Get full text
Journal Article -
13
Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma
Published in Medicine (Baltimore) (01-09-2018)“…T cell infiltration in tumors has been investigated as a biomarker of response to checkpoint inhibitors. Neo-adjuvant studies in renal cell carcinoma (RCC) may…”
Get full text
Journal Article -
14
GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway
Published in PloS one (30-07-2015)“…Previously we demonstrated that human glioblastoma cell lines induce apoptosis in peripheral blood T cells through partial involvement of secreted…”
Get full text
Journal Article -
15
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
Published in Targeted oncology (01-10-2018)“…Background The identification of prognostic and/or predictive biomarkers for response to immune checkpoint inhibitors (ICI) could help guide treatment…”
Get full text
Journal Article -
16
GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells
Published in Cancer research (Chicago, Ill.) (01-04-2009)“…We previously elucidated an important role for gangliosides in renal cell carcinoma-mediated T lymphocyte apoptosis, although the mechanism by which they…”
Get full text
Journal Article -
17
Myeloid-derived Suppressor Cells Adhere to Physiologic STAT3- vs STAT5-dependent Hematopoietic Programming, Establishing Diverse Tumor-Mediated Mechanisms of Immunologic Escape
Published in Immunological investigations (01-08-2012)“…The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and…”
Get full text
Journal Article -
18
Differential gene expression in G-MDSC and neutrophils from renal cell carcinoma patients
Published in Journal for immunotherapy of cancer (06-11-2014)“…Myeloid-derived suppressor cells (MDSC), including undifferentiated, monocytic, and granulocytic subsets, are known to play a role in tumor progression via…”
Get full text
Journal Article -
19
IL-12 stimuli during ex vivo expansion not only prevents the upregulation of PD1 on tumor infiltrating adoptively transferred T cells but also on endogenous TILs which results in effective tumor regression
Published in Journal for immunotherapy of cancer (06-11-2014)“…The blockade of negative immune regulators such as CTLA-4 and PD1 continues to show encouraging results in patients with solid malignancies. The efficacy of…”
Get full text
Journal Article -
20
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses
Published in Clinical cancer research (15-09-2004)“…Purpose: We reported that in renal cell carcinoma patients with active disease, T-cell reactions to the tumor-associated antigens MAGE-6 and EphA2 are highly…”
Get full text
Journal Article Conference Proceeding